Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paolo Borghetti

Showing results (51-60 of 130) with videos related to

Pageof 13
Sort By:
Comparative Immunology, Microbiology and Infectious Diseases|August 8, 2020
An engineered anti-idiotypic antibody-derived killer peptide (KP) early activates swine inflammatory monocytes, CD3<sup>+</sup>CD16<sup>+</sup> natural killer T cells and CD4<sup>+</sup>CD8α<sup>+</sup> double positive CD8β<sup>+</sup> cytotoxic T lymphocytes associated with TNF-α and IFN-γ secretionLuca Ferrari, Paolo Martelli, Roberta Saleri, et al.
Frontiers in Veterinary Science|March 31, 2023
Nano-adjuvanted dry powder vaccine for the mucosal immunization against airways pathogensElena Canelli, Luca Ferrari, Paolo Borghetti, et al.
Frontiers in Veterinary Science|April 10, 2026
Combination of hypoxia and hyperosmolarity reduces <i>in vitro</i> chondrocyte de-differentiationElena De Angelis, Roberta Saleri, Filippo Marcotti, et al.
Tumori|June 24, 2021
Prevention and management of acute esophageal toxicity during concomitant chemoradiotherapy for locally advanced lung cancerPaolo Borghetti, Jessica Imbrescia, Giulia Volpi, et al.
Lung Cancer (Amsterdam, Netherlands)|November 5, 2025
Recommendations for radiotherapy in patients with lung cancer and interstitial lung disease: A Delphi consensus process of the Italian association of radiotherapy and clinical oncology (AIRO)Paolo Borghetti, Rolando D'Angelillo, Giorgio Facheris, et al.
Journal of Clinical Medicine|July 29, 2025
Lung Stereotactic Body Radiotherapy (SBRT): Challenging Scenarios and New FrontiersSerena Badellino, Francesco Cuccia, Marco Galaverni, et al.
Research in Veterinary Science|June 26, 2017
The in vitro biocompatibility of d-(+) raffinose modified chitosan: Two-dimensional and three-dimensional systems for culturing of horse articular chondrocytesElena De Angelis, Francesca Ravanetti, Paolo Martelli, et al.
Radiation Oncology (London, England)|July 16, 2022
Chemo-radiotherapy plus durvalumab for loco-regional relapse of resected NSCLCPaolo Borghetti, Jessica Imbrescia, Giulia Volpi, et al.
In Vivo (Athens, Greece)|April 30, 2024
Artificial Intelligence-suggested Predictive Model of Survival in Patients Treated With Stereotactic Radiotherapy for Early Lung CancerPaolo Borghetti, Gianluca Costantino, Valeria Santoro, et al.
Expert Review of Anticancer Therapy|December 18, 2016
From chemotherapy to target therapies associated with radiation in the treatment of NSCLC: a durable marriage?Filippo Alongi, Stefano Arcangeli, Sara Ramella, et al.
Pageof 13

Showing results (51-60 of 130) with videos related to

Sort By:
Pageof 13
Comparative Immunology, Microbiology and Infectious Diseases|August 8, 2020
An engineered anti-idiotypic antibody-derived killer peptide (KP) early activates swine inflammatory monocytes, CD3<sup>+</sup>CD16<sup>+</sup> natural killer T cells and CD4<sup>+</sup>CD8α<sup>+</sup> double positive CD8β<sup>+</sup> cytotoxic T lymphocytes associated with TNF-α and IFN-γ secretionLuca Ferrari, Paolo Martelli, Roberta Saleri, et al.
Frontiers in Veterinary Science|March 31, 2023
Nano-adjuvanted dry powder vaccine for the mucosal immunization against airways pathogensElena Canelli, Luca Ferrari, Paolo Borghetti, et al.
Frontiers in Veterinary Science|April 10, 2026
Combination of hypoxia and hyperosmolarity reduces <i>in vitro</i> chondrocyte de-differentiationElena De Angelis, Roberta Saleri, Filippo Marcotti, et al.
Tumori|June 24, 2021
Prevention and management of acute esophageal toxicity during concomitant chemoradiotherapy for locally advanced lung cancerPaolo Borghetti, Jessica Imbrescia, Giulia Volpi, et al.
Lung Cancer (Amsterdam, Netherlands)|November 5, 2025
Recommendations for radiotherapy in patients with lung cancer and interstitial lung disease: A Delphi consensus process of the Italian association of radiotherapy and clinical oncology (AIRO)Paolo Borghetti, Rolando D'Angelillo, Giorgio Facheris, et al.
Journal of Clinical Medicine|July 29, 2025
Lung Stereotactic Body Radiotherapy (SBRT): Challenging Scenarios and New FrontiersSerena Badellino, Francesco Cuccia, Marco Galaverni, et al.
Research in Veterinary Science|June 26, 2017
The in vitro biocompatibility of d-(+) raffinose modified chitosan: Two-dimensional and three-dimensional systems for culturing of horse articular chondrocytesElena De Angelis, Francesca Ravanetti, Paolo Martelli, et al.
Radiation Oncology (London, England)|July 16, 2022
Chemo-radiotherapy plus durvalumab for loco-regional relapse of resected NSCLCPaolo Borghetti, Jessica Imbrescia, Giulia Volpi, et al.
In Vivo (Athens, Greece)|April 30, 2024
Artificial Intelligence-suggested Predictive Model of Survival in Patients Treated With Stereotactic Radiotherapy for Early Lung CancerPaolo Borghetti, Gianluca Costantino, Valeria Santoro, et al.
Expert Review of Anticancer Therapy|December 18, 2016
From chemotherapy to target therapies associated with radiation in the treatment of NSCLC: a durable marriage?Filippo Alongi, Stefano Arcangeli, Sara Ramella, et al.
Pageof 13